Scientists probe why Weight-Loss drug works for some teens, not others
NCT ID NCT04986631
Summary
This study aims to understand why the weight-loss medication topiramate works well for some teens with severe obesity but not for others. Researchers will measure drug levels in the blood of 62 participants aged 12-18 over 3.5 months to see how the body processes the drug and connects that to changes in weight and eating habits. The goal is to gather information that could help doctors personalize dosing in the future to improve treatment effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY, CHILDHOOD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Conditions
Explore the condition pages connected to this study.